1. Trenk D, Nührenberg T, Stratz C, Valina CM, Hochholzer W. Clinical pharmacology of current antiplatelet drugs. Cardiovascul Dis (Germ) 2014;39:790–797.
2. Bueno H, Pocock S, Danchin N, Annemans L, Medina J, Millegard M, et al. EPICOR: an international study of the duration of dual antiplatelet therapy in survivors of acute coronary syndromes. Circulation 2014;130:A16705–A16705.
3. Tang XF, Fan JY, Meng J, Jin C, Yuan JQ, Yang YJ. Impact of new oral or intravenous P2Y12 inhibitors and clopidogrel on major ischemic and bleeding events in patients with coronary artery disease: a meta-analysis of randomized trials. Atherosclerosis 2014;233:568–578.
4. Tantry US, Gesheff M, Liu F, Bliden KP, Gurbel PA. Resistance to antiplatelet drugs: what progress has been made? Expert Opin Pharmacother 2014;15:2553–2564.
5. Yao H, Zhang JP, Chen ZX, Li ZQ. Effects of Buyang Huanwu Decoction and Astragalus Mongholicus on PAF receptor activity in rabbits in vitro. J Tradit Chin Med (Chin) 2006;17:613–615.